Revitalizing Antibiotics: Strategies to Combat Resistance and Restore Effectiveness †
Abstract
:1. Introduction
2. Antibiotic Resistance Mechanisms
2.1. Genetic Mutations
2.2. Horizontal Gene Transfer
2.3. Biofilm Formation
2.4. Efflux Pumps
2.5. Reduced Permeability
3. The Global Impact of Antibiotic Resistance
3.1. Human Health
- Treatment failures: Infections that are resistant to antibiotics can be hard to treat, which can make people sick longer, kill more people, and require antibiotics that are more expensive or harmful.
- Increased healthcare costs: It can be hard on healthcare budgets to treat infections that are resistant because they often require longer hospital stays, more diagnostic tests, and more expensive drugs.
- Public health threat: It is dangerous for the public’s health when resistant bacteria get around in communities and healthcare settings. It gets harder to take care of common infections like urinary tract infections and surgical site infections [2].
3.2. Animal Health
- Agricultural use: A lot of antibiotics are used in farming to help animals grow and stay healthy when they are crowded together. This makes it easier for bacteria that are resistant to antibiotics to grow in animals.
- Food safety concerns: Resistance bacteria can be passed from one food source to another, which could be bad for people’s health. People can get resistant pathogens from meat, milk, and other animal products that have been tainted [7].
3.3. Environmental Impact
- Antibiotic residues: Healthcare facilities and farms can pollute water and soil by dumping antibiotics and bacteria that are resistant to antibiotics into wastewater that then gets into the environment.
- Ecological consequences: Genes that make bacteria resistant to antibiotics can be passed on to bacteria in the environment. This could change natural microbial communities and the way ecosystems work [8].
3.4. Economic Consequences
- Increased healthcare expenditure: As the number of infections that are resistant to antibiotics rises, healthcare costs rise, including higher costs for hospital stays and medicines;
- Loss of productivity: People who are sick, including people who work, may be less productive because they take longer to get better or become disabled because of infections that are resistant to treatment;
- Impact on agriculture: Animals that are resistant to antibiotics can hurt agricultural production, which could cost the farming industry money [9].
4. Strategies to Combat Antibiotic Resistance
4.1. Stewardship Programs
4.2. Antibiotic Development
4.3. Combination Therapy
4.4. Phage Therapy
4.5. Immunotherapies
4.6. Alternative Therapies
5. The Role of a One-Health Approach
5.1. Human-Animal-Environment Connection
5.2. Surveillance and Data Sharing
- In human health: It is recommended that healthcare professionals support antibiotic stewardship programmes, encourage infection control measures, and prescribe antibiotics in a way that does not cause resistance.
- In Animal Health: Veterinarians and people who raise animals for food encourage animals to use antibiotics responsibly, limit the use of antibiotics to help animals grow and take steps to stop the spread of bacteria that are resistant to antibiotics in animal populations.
- In the environment: Antibiotic residues and their effect on resistance are tracked and managed by environmental agencies. They also figure out how things in the environment, like pollution, affect driving resistance.
- Data Sharing and Research: Researchers and agencies that work on human health, animal health, and the environment can better understand how antibiotic resistance works when they work together. This includes looking into the genetic causes of resistance, following its spread, and figuring out where help is most needed [16].
6. The Importance of Public Awareness
6.1. Healthcare Provider Education
6.2. Patient Education
6.3. Responsible Antibiotic Use
7. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Piddock, L.J.V. Understanding the basis of antibiotic resistance: A platform for drug discovery. Microbiology 2014, 160 Pt 11, 2366–2373. [Google Scholar] [CrossRef] [PubMed]
- Ventola, C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm. Ther. 2015, 40, 277–283. [Google Scholar]
- Smillie, C.S.; Smith, M.B.; Friedman, J.; Cordero, O.X.; David, L.A.; Alm, E.J. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 2011, 480, 241–244. [Google Scholar] [CrossRef] [PubMed]
- Costerton, J.W.; Stewart, P.S.; Greenberg, E.P. Bacterial biofilms: A common cause of persistent infections. Science 1999, 284, 1318–1322. [Google Scholar] [CrossRef] [PubMed]
- Poole, K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 2005, 56, 20–51. [Google Scholar] [CrossRef] [PubMed]
- Nikaido, H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. MMBR 2003, 67, 593–656. [Google Scholar] [CrossRef] [PubMed]
- Morley, P.S.; Apley, M.D.; Besser, T.E.; Burney, D.P.; Fedorka-Cray, P.J.; Papich, M.G.; Traub-Dargatz, J.L.; Scott Weese, J. Antimicrobial drug use in veterinary medicine. J. Vet. Intern. Med. 2005, 19, 617–629. [Google Scholar] [CrossRef] [PubMed]
- Knapp, C.W.; McCluskey, S.M.; Singh, B.K.; Campbell, C.D.; Hudson, G.; Graham, D.W. Antibiotic Resistance Gene Abundances Correlate with Metal and Geochemical Conditions in Archived Scottish Soils. PLoS ONE 2011, 6, e27300. [Google Scholar] [CrossRef] [PubMed]
- Poudel, A.N.; Zhu, S.; Cooper, N.; Little, P.; Tarrant, C.; Hickman, M.; Yao, G. The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLoS ONE 2023, 18, e0285170. [Google Scholar] [CrossRef] [PubMed]
- Mas-Morey, P.; Valle, M. A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-medium-sized hospitals. Eur. J. Hosp. Pharm. Sci. Pract. 2018, 25, e69–e73. [Google Scholar] [CrossRef] [PubMed]
- Penesyan, A.; Gillings, M.; Paulsen, I.T. Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities. Molecules 2015, 20, 5286–5298. [Google Scholar] [CrossRef] [PubMed]
- Boyd, N.; Nailor, M. Combination Antibiotic Therapy for Empiric and Definitive Treatment of Gram-Negative Infections: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2011, 31, 1073–1084. [Google Scholar] [CrossRef] [PubMed]
- Moye, Z.D.; Woolston, J.; Sulakvelidze, A. Bacteriophage Applications for Food Production and Processing. Viruses 2018, 10, 205. [Google Scholar] [CrossRef] [PubMed]
- Ramamurthy, D.; Nundalall, T.; Cingo, S.; Mungra, N.; Karaan, M.; Naran, K.; Barth, S. Recent advances in immunotherapies against infectious diseases. Immunother. Adv. 2021, 1, ltaa007. [Google Scholar] [CrossRef]
- Behravesh, C.B. One Health: People, Animals, and the Environment. Emerg. Infect. Dis. 2016, 22, 766–767. [Google Scholar] [CrossRef]
- Velazquez-Meza, M.E.; Galarde-López, M.; Carrillo-Quiróz, B.; Alpuche-Aranda, C.M. Antimicrobial resistance: One Health approach. Vet. World 2022, 15, 743–749. [Google Scholar] [CrossRef] [PubMed]
- Mainous, A.G., 3rd; Lambourne, C.A.; Nietert, P.J. Impact of a clinical decision support system on antibiotic prescribing for acute respiratory infections in primary care: Quasi-experimental trial. J. Am. Med. Inform. Assoc. JAMIA 2013, 20, 317–324. [Google Scholar] [CrossRef] [PubMed]
- Althagafi, N.S.; Othman, S.S. Knowledge, attitude, and practice of antibiotics use among primary healthcare physicians, Ministry of Health, Jeddah. J. Fam. Med. Prim. Care 2022, 11, 4382–4388. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mishra, D.K.; Dixit, I.; Chaudhari, S.; Yadav, S.; Tiwari, L.; Waheed, K.A.; Upadhyay, S. Revitalizing Antibiotics: Strategies to Combat Resistance and Restore Effectiveness. Med. Sci. Forum 2024, 24, 4. https://doi.org/10.3390/ECA2023-16391
Mishra DK, Dixit I, Chaudhari S, Yadav S, Tiwari L, Waheed KA, Upadhyay S. Revitalizing Antibiotics: Strategies to Combat Resistance and Restore Effectiveness. Medical Sciences Forum. 2024; 24(1):4. https://doi.org/10.3390/ECA2023-16391
Chicago/Turabian StyleMishra, Devendra Kumar, Ila Dixit, Sumit Chaudhari, Sandeep Yadav, Lavkush Tiwari, Khalid Abdul Waheed, and Savita Upadhyay. 2024. "Revitalizing Antibiotics: Strategies to Combat Resistance and Restore Effectiveness" Medical Sciences Forum 24, no. 1: 4. https://doi.org/10.3390/ECA2023-16391
APA StyleMishra, D. K., Dixit, I., Chaudhari, S., Yadav, S., Tiwari, L., Waheed, K. A., & Upadhyay, S. (2024). Revitalizing Antibiotics: Strategies to Combat Resistance and Restore Effectiveness. Medical Sciences Forum, 24(1), 4. https://doi.org/10.3390/ECA2023-16391